Clearmind gets DSMB approval to test CMND-100 in AUD patients
Go back to Clearmind gets DSMB approval to test CMND-100 in AUD patients| (NASDAQ: CMND) | Delayed: 1.03 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.03 | 52 Week High | $ | |||
| Open | $1.03 | 52 Week Low | $ | |||
| Day High | $1.03 | P/E | N/A | |||
| Day Low | $1.03 | EPS | $ | |||
| Volume | 42,494 | |||||

